Collaborating Proteins, Affected Histone Modifications and Targets of the ALL-1 P

协作蛋白、受影响的组蛋白修饰和 ALL-1 P 的靶标

• 批准号: 7617338
• 负责人: ELI CANAANI
• 金额: $ 19.74万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2013-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7617338
• 关键词: 11q23; ASCL1 gene; Acute leukemia; Affect; Biological Process; Cells; Chimeric Proteins; Chromatin; Chromosome abnormality; Chronic Lymphocytic Leukemia; Cloning; Complex; Data; Deposition; Enzymes; Epigenetic Process; Etiology; Foundations; Gene Targeting; Genes; Genomics; Hematopoietic; Histones; Human; Human Cloning; Human Resources; Investigation; Last Name; Leukemic Cell; Location; MLL gene; MLLT2 gene; MLLT3 gene; Methylation; Methyltransferase; Multiprotein Complexes; Names; Pathogenesis; Phosphotransferases; Polycomb; Positive Transcriptional Elongation Factor B; Principal Investigator; Proteins; Recruitment Activity; Role; Technology; Testing; Transcription Elongation; Work; base; gene cloning; histone modification; insight; programs; small hairpin RNA

Usecontinuationpages as neededto provide the required information in the format shown below. Start with Program Director(s)/Principal Investigator(s). List all other senior/key personnel in alphabetical order, last name first. Name eRA Commons User Name Organization Role on

根据需要提供的USECONTINUATIONPAGES以下面显示的格式提供所需的信息。 从计划主管/首席研究员开始。按字母顺序列出所有其他高级/关键人员，首先姓氏。 名称ERA CONSONS用户名称组织角色